Restricted accessResearch articleFirst published online 2017-02
Preintervention Profiles of Information,Motivational,and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men
Although rates of crystal methamphetamine use in the United States have fallen from their peak in the mid-2000s, use remains a major public health concern, which disproportionately affects gay and bisexual men (GBM). It poses a particular challenge for HIV-positive men, for whom it has been linked to medication adherence problems as well as compromised immune function. Although the information, motivation, and behavioral skills (IMB) model has been widely used to conceptualize health behavior, little is known about GBM's initial levels of information, motivation, and behavioral self-efficacy to improve HIV medication adherence and to reduce crystal methamphetamine use at the outset of treatment. The present study identified profiles of IMB factors related to HIV medication adherence and crystal methamphetamine use in a sample of 210 HIV-positive GBM who consented to participate in an intervention study. Results indicated three distinct patterns of IMB factors. The largest group was ready to change both adherence and methamphetamine use (n = 104). This group also had depression scores that were significantly lower than other groups. A second group appeared ready to change medication adherence, but was ambivalent about changing methamphetamine use (n = 60). This group reported significantly more symptoms of methamphetamine dependence than the other groups. A third group was characterized by global IMB barriers to change (n = 46). Results are discussed in the context of tailoring psychoeducation, motivational interviewing, and cognitive behavioral interventions to match these preintervention patterns of IMB factors.
Get full access to this article
View all access options for this article.
References
1.
FeldmanM, ThomasJ, AlexyE, IrvineM. Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York. Drug Alcohol Depend, 2014; 147:266–271.
2.
PantaloneDW, BimbiDS, HolderCA, GolubSA, ParsonsJT. Consistency and change in club drug use by sexual minority men in New York City, 2002 to 2007. Am J Public Health, 2010; 100:1892–1895.
3.
ShoptawS, RebackCJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: Implications for interventions. Addiction, 2007; 102Suppl 1:130–135.
4.
StaleyP. It's back! Meth use by NYC gay men rising again. 2016. Available at: https://www.poz.com/blog/meth-use-by-nyc-gay-men-rising-again (Last accessed February2, 2016).
5.
MayerKH, O'CleirighC, SkeerM, et al.Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: Findings from a Boston community health centre. Sex Transm Infect, 2010; 86:66–70.
6.
RebackCJ, FletcherJB, ShoptawS, GrellaCE. Methamphetamine and other substance use trends among street-recruited men who have sex with men, from 2008 to 2011. Drug Alcohol Depend, 2013; 133:262–265.
7.
SkeerM, MimiagaM, MayerK, O'CleirighC, CovaheyC, SafrenS. Patterns of substance use among a large urban cohort of HIV-infected men who have sex with men in primary care. AIDS Behav, 2012; 16:676–689.
8.
ForrestDW, MetschLR, LaLotaM, CardenasG, BeckDW, JeantyY. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health, 2010; 87:480–485.
9.
VaudreyJ, RaymondHF, ChenS, HechtJ, AhrensK, McFarlandW. Indicators of use of methamphetamine and other substances among men who have sex with men, San Francisco, 2003–2006. Drug Alcohol Depend, 2007; 90:97–100.
10.
SchwarczS, ScheerS, McFarlandW, et al.Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health, 2007; 97:1067–1075.
11.
GrovC, ParsonsJT, BimbiDS. In the shadows of a prevention campaign: Sexual risk behavior in the absence of crystal methamphetamine. AIDS Educ Prev, 2008; 20:42–55.
12.
GrovC, RendinaHJ, VentuneacA, ParsonsJT. HIV risk in group sexual encounters: An event-level analysis from a national online survey of MSM in the U.S. J Sex Med, 2013; 10:2285–2294.
13.
RajasinghamR, MimiagaMJ, WhiteJM, PinkstonMM, BadenRP, MittyJA. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDS, 2012; 26:36–52.
14.
CarricoAW, Woolf-KingSE, NeilandsTB, DilworthSE, JohnsonMO. Stimulant use and HIV disease management among men in same-sex relationships. Drug Alcohol Depend, 2014; 1:174–177.
15.
ParsonsJT, KowalczykWJ, BotskoM, TomassilliJC, GolubSA. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS Behav, 2013; 17:1478–1487.
16.
CarricoAW, ShoptawS, CoxC, et al.Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2014; 67:508–513.
17.
CarricoAW. Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIV. Life Sci, 2011; 88:940–947.
18.
ToussiSS, JosephA, ZhengJH, DuttaM, SantambrogioL, GoldsteinH. Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res Hum Retroviruses, 2009; 25:1117–1121.
19.
ColfaxG, VittinghoffE, GrantR, LumP, SpottsG, HechtF. Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS Behav, 2007; 21:239–241.
20.
GorbachP, DrumrightL, JavanbakhtM, et al.Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr, 2008; 47:639–643.
21.
JaffeA, ShoptawS, SteinJ, RebackC, Rotheram-FullerE. Depression ratings, reported sexual risk behaviors, and methamphetamine use: Latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Exp Clin Psychopharmacol, 2007; 15:301–307.
22.
PeckJ, RebackC, YangX, Rotheram-FullerE, ShoptawS. Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. J Urban Health, 2005; 82(1 suppl 1):i100–i108.
FletcherJ, RebackC. Depression mediates and moderates effects of methamphetamine use on sexual risk taking among treatment-seeking gay and bisexual men. Health Psychol, 2015; 34:865–869.
25.
CareyCL, WoodsSP, RippethJD, et al.Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav, 2006; 10:185–190.
26.
CarricoAW, PollackLM, StallRD, et al.Psychological processes and stimulant use among men who have sex with men. Drug Alcohol Depend, 2012; 123:79–83.
27.
ShoptawS, PeckJ, RebackCJ, Rotheram-FullerE. Psychiatric and substance dependence comorbidities, sexual transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J Psychoactive Drugs, 2003; 35(Suppl 1):161–168.
FisherJD, FisherWA, AmicoKR, HarmanJJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol, 2006; 25:462–473.
30.
NortonWE, AmicoKR, FisherWA, et al.Information-motivation-behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV+ patients in clinical care. AIDS Care, 2010; 22:979–987.
31.
AmicoKR, BartaW, Konkle-ParkerDJ, et al.The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample. AIDS Behav, 2009; 13:66–75.
32.
RyanRM, PlantRW, O'MalleyS. Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout. Addict Behav, 1995; 20:279–297.
33.
ZeldmanA, RyanRM, FiscellaK. Motivation, autonomy support, and entity beliefs: Their role in methadone maintenance treatment. J Soc Clin Psychol, 2004; 23:675–696.
34.
AndersonES, WagstaffDA, HeckmanTG, et al.Information-motivation-behavioral skills (IMB) model: Testing direct and mediated treatment effects on condom use among women in low-income housing. Ann Behav Med, 2006; 2:70–79.
35.
PitpitanE, KalichmanSC, GarciaR, CainD, EatonLA, SimbayiL. Mediators of behavior change resulting from a sexual risk reduction intervention for STI patients, Cape Town, South Africa. J Behav Med, 2015; 38:194–203.
36.
ParsonsJT, KellyBC, WeiserJD. Initiation into methamphetamine use for young gay and bisexual men. Drug Alcohol Depend, 2007; 90:135–144.
37.
KellyBC, ParsonsJT. Prescription drug misuse and sexual risk taking among HIV-negative MSM. AIDS Behav, 2013; 17:926–930.
38.
ProchaskaJO, VelicerWF, RossiJS, et al.Stages of change and decisional balance for 12 problem behaviors. Health Psychol, 1994; 13:39–46.
39.
AnnisHM, SklarSM, TurnerNE. The Drug-Taking Confidence Questionnaire: User's Guide. Toronto, Canada: Addiction Research Foundation of Ontario, 1997.
40.
ParsonsJT, RosofE, MustanskiB. Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. J Health Psychol, 2007; 12:357–370.
41.
ParsonsJT, RosofE, MustanskiB. The temporal relationship between alcohol consumption and HIV-medication adherence: A multilevel model of direct and moderating effects. Health Psychol, 2008; 27:628–637.
42.
ParsonsJT, RosofE, PunzalanJC, DiMariaL. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: Results of a pilot project. AIDS Patient Care STDS, 2005; 19:31–39.
43.
RadloffLS. The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas, 1977; 1:385–401.
44.
SobellMB, SobellLC. Problem Drinkers: Guided Self-Change Treatment. New York: Guilford Press, 1993.
NylundKL, AsparouhovT, MuthenBO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct Equ Modeling, 2007; 14:535–569.
47.
CeleuxG, SoromenhoG. An entropy criterion for assessing the number of clusters in a mixture model. J Classif, 1996; 13:195–212.
48.
JacobsR, CaballeroJ, OwnbyR, KaneM. Development of a culturally appropriate computer-delivered tailored internet-based health literacy intervention for spanish-dominant hispanics living with HIV. BMC Med Inform Decis Mak, 2014; 14:1–10.
49.
MillerW, RollnickS. Motivational Interviewing: Preparing People for Change. 2nd edition. New York: The Guilford Press, 2002.
50.
ParsonsJT, GolubSA, RosofE, HolderC. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence mong hazardous drinkers: A Randomized controlled trial. J Acquir Immune Defic Syndr, 2007; 46:443–450.
